Abstract
Largely due to population ageing, the cancer burden from older people has been rising, which imposed considerable pressure on current Chinese healthcare system. We provide comprehensive information about cancer burden of Chinese older people based on the most recent data from National Central Cancer Registry of China. The logarithmic linear regression was used to project the current cancer burden in 2022, and Joinpoint regression was used for temporal trend analysis from 2000 to 2017. We also estimated cancer statistics of older people in the US, Japan and the Republic of Korea for comparisons. It is estimated that 2.79 million cases and 1.94 million deaths occur for Chinese older people, representing 55.8% and 68.2% of cases and deaths in all population in 2022. The overall cancer incidence rate gradually increased among older women, while the mortality rates declined for both sexes. Notably, approximately 10.0% of all cases and 17.7% of all deaths are from people aged over 80 years, and cancer incidence and mortality in this age group showed upward trends for women. Lung cancer and digestive cancers are the leading cancer types for Chinese older people. Compared with other countries, China has lower incidence rates but higher mortality rates for older people. The rapidly growing burden of prostate cancer, breast cancer, colorectal cancer, and declines in esophageal cancer, stomach cancer, and liver cancer among older people indicate the cancer pattern in China is being in a transition stage to that in developed countries. Our findings imply that it should be the national health priority to meet the growing demands for cancer diagnosis, treatment and care services from the older people as the rapid population ageing in next few decades.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arnold, M., Rutherford, M.J., Bardot, A., Ferlay, J., Andersson, T.M.L., Myklebust, T.Å., Tervonen, H., Thursfield, V., Ransom, D., Shack, L., et al. (2019). Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol 20, 1493–1505.
Bai, F., Wang, L., Wang, Y. (2018). Economic evaluation of liver cancer screening in China: A systematic review. Chin J Evid-Based Med 18, 8.
Barengo, N.C., Antikainen, R., Harald, K., and Jousilahti, P. (2019). Smoking and cancer, cardiovascular and total mortality among older adults: The Finrisk Study. Prev Med Rep 14, 100875.
Brassell, S.A., Rice, K.R., Parker, P.M., Chen, Y., Farrell, J.S., Cullen, J., and McLeod, D.G. (2011). Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes. J Urol 185, 132–137.
Bray, F., and Parkin, D.M. (2009). Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 45, 747–755.
Chalkidou, K., Marquez, P., Dhillon, P.K., Teerawattananon, Y., Anothaisintawee, T., Gadelha, C.A.G., and Sullivan, R. (2014). Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol 15, e119–e131.
Chao, A., Connell, C.J., Jacobs, E.J., McCullough, M.L., Patel, A.V., Calle, E.E., Cokkinides, V.E., and Thun, M.J. (2004). Amount, type, and timing of recreational physical activity in relation to colon and rectal cancer in older adults: the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prevention 13, 2187–2195.
Chen, H., Li, N., Ren, J., Feng, X., Lyu, Z., Wei, L., Li, X., Guo, L., Zheng, Z., Zou, S., et al. (2019). Participation and yield of a population-based colorectal cancer screening programme in China. Gut 68, 1450–1457.
Chen, J.G., Egner, P.A., Ng, D., Jacobson, L.P., Muñoz, A., Zhu, Y.R., Qian, G.S., Wu, F., Yuan, J.M., Groopman, J.D., et al. (2013). Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev Res 6, 1038–1045.
Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q., and He, J. (2016). Cancer statistics in China, 2015. CA-Cancer J Clin 66, 115–132.
DeSantis, C.E., Miller, K.D., Dale, W., Mohile, S.G., Cohen, H.J., Leach, C.R., Goding Sauer, A., Jemal, A., and Siegel, R.L. (2019). Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin 69, 452–467.
Fan, L., Strasser-Weippl, K., Li, J.J., St Louis, J., Finkelstein, D.M., Yu, K. D., Chen, W.Q., Shao, Z.M., and Goss, P.E. (2014). Breast cancer in China. Lancet Oncol 15, e279–e289.
Fang, E.F., Xie, C., Schenkel, J.A., Wu, C., Long, Q., Cui, H., Aman, Y., Frank, J., Liao, J., Zou, H., et al. (2020). A research agenda for ageing in China in the 21st century (2nd edition): focusing on basic and translational research, long-term care, policy and social networks. Ageing Res Rev 64, 101174.
Fang, P., He, W., Gomez, D.R., Hoffman, K.E., Smith, B.D., Giordano, S. H., Jagsi, R., and Smith, G.L. (2017). Influence of age on guideline-concordant cancer care for elderly patients in the United States. Int J Radiat Oncol Biol Phys 98, 748–757.
Faraway, J.J. (2009). Linear Models with R. (Boca Raton: Chapman & Hall).
Forman, D, Bray, F., Brewster, D. (2013). Cancer Incidence in Five Continents, Vol. X (electronic version).
Goss, P.E., Strasser-Weippl, K., Lee-Bychkovsky, B.L., Fan, L., Li, J., Chavarri-Guerra, Y., Liedke, P.E.R., Pramesh, C.S., Badovinac-Crnjevic, T., Sheikine, Y., et al. (2014). Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 15, 489–538.
Grant, M., Elk, R., Ferrell, B., Morrison, R.S., and von Gunten, C.F. (2009). Current status of palliative care-clinical implementation, education, and research. CA-Cancer J Clin 59, 327–335.
Hartman, M., Drotman, M., and Arleo, E.K. (2015). Annual screening mammography for breast cancer in women 75 years old or older: to screen or not to screen. Am J Roentgenol 204, 1132–1136.
He, J., Wei, W., National Cancer Center. (2021). China Cancer Registry Annual Report, 2019. (Beijing: People’s Medical Publishing House Co. Ltd).
Hou, J., Wang, G., Wang, F., Cheng, J., Ren, H., Zhuang, H., Sun, J., Li, L., Li, J., Meng, Q., et al. (2017). Guideline of prevention and treatment for chronic hepatitis B (2015 update). J Clin Transl Hepatol 5, 297–318.
Hurria, A. (2013). Management of elderly patients with cancer. J Natl Compr Canc Netw 11, 698–701.
Islami, F., Chen, W., Yu, X.Q., Lortet-Tieulent, J., Zheng, R., Flanders, W. D., Xia, C., Thun, M.J., Gapstur, S.M., Ezzati, M., et al. (2017). Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013. Ann Oncol 28, 2567–2574.
Ito, K. (2014). Prostate cancer in Asian men. Nat Rev Urol 11, 197–212.
Ito, K., Oki, R., Sekine, Y., Arai, S., Miyazawa, Y., Shibata, Y., Suzuki, K., and Kurosawa, I. (2019). Screening for prostate cancer: history, evidence, controversies and future perspectives toward individualized screening. Int J Urol 26, 956–970.
Jankovic, N., Geelen, A., Winkels, R.M., Mwungura, B., Fedirko, V., Jenab, M., Illner, A.K., Brenner, H., Ordóñez-Mena, J.M., Kiefte de Jong, J.C., et al. (2017). Adherence to the WCRF/AICR dietary recommendations for cancer prevention and risk of cancer in elderly from Europe and the United States: a meta-analysis within the CHANCES project. Cancer Epidemiol Biomarkers Prevent 26, 136–144.
Jung, M. (2015). National Cancer Screening Programs and evidence-based healthcare policy in South Korea. Health Policy 119, 26–32.
Kamangar, F., Chow, W.H., C. Abnet, C., and M. Dawsey, S. (2009). Environmental causes of esophageal cancer. Gastroenterol Clin N Am 38, 27–57.
Kim, Y., Park, J., Nam, B.H., and Ki, M. (2015). Stomach cancer incidence rates among Americans, Asian Americans and Native Asians from 1988 to 2011. Epidemiol Health 37, e2015006.
Lam, T.H., Li, Z.B., Ho, S.Y., Chan, W.M., Ho, K.S., Tham, M.K., Cowling, B.J., Schooling, C.M., and Leung, G.M. (2007). Smoking, quitting and mortality in an elderly cohort of 56 000 Hong Kong Chinese. Tobacco Control 16, 182–189.
Li, M., Sun, Y., Yang, J., de Martel, C., Charvat, H., Clifford, G.M., Vaccarella, S., and Wang, L. (2020). Time trends and other sources of variation in Helicobacter pylori infection in mainland China: a systematic review and meta-analysis. Helicobacter 25, e12729.
Lim, S.H., Tai, B.C., Yuan, J.M., Yu, M.C., and Koh, W.P. (2013). Smoking cessation and mortality among middle-aged and elderly Chinese in Singapore: the Singapore Chinese Health Study. Tob Control 22, 235–240.
Lu, Y., Gu, Y., and Yu, W. (2018). Hospice and palliative care in China: development and challenges. Asia-Pac J Oncol Nurs 5, 26–32.
Mabe, K., Inoue, K., Kamada, T., Kato, K., Kato, M., and Haruma, K. (2022). Endoscopic screening for gastric cancer in Japan: current status and future perspectives. Digestive Endoscopy 34, 412–419.
Malvezzi, M., Arfé, A., Bertuccio, P., Levi, F., La Vecchia, C., and Negri, E. (2011). European cancer mortality predictions for the year 2011. Ann Oncol 22, 947–956.
Parkin, D.M., and Bray, F. (2009). Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 45, 756–764.
Du, P., Wang, W.L. (2010). The difference of urban and rural ageing and its transition. Populat Res 34, 3–10.
Quaresma, M., Coleman, M.P., and Rachet, B. (2015). 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study. Lancet 385, 1206–1218.
Siegel, R.L., Miller, K.D., Fuchs, H.E., and Jemal, A. (2022). Cancer statistics, 2022. CA Cancer J Clin 72, 7–33.
Smith, R.A., Andrews, K.S., Brooks, D., Fedewa, S.A., Manassaram-Baptiste, D., Saslow, D., and Wender, R.C. (2019). Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 69, 184–210.
Simon, K. (2016). Colorectal cancer development and advances in screening. CIA Volume 11, 967–976.
Sun, D., Cao, M., Li, H., He, S., and Chen, W. (2020). Cancer burden and trends in China: a review and comparison with Japan and South Korea. Chin J Cancer Res 32, 129–139.
Sun, Z., Chen, T., Thorgeirsson, S.S., Zhan, Q., Chen, J., Park, J.H., Lu, P., Hsia, C.C., Wang, N., Xu, L., et al. (2013). Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis 34, 1800–1805.
Tamiya, N., Noguchi, H., Nishi, A., Reich, M.R., Ikegami, N., Hashimoto, H., Shibuya, K., Kawachi, I., and Campbell, J.C. (2011). Population ageing and wellbeing: lessons from Japan’s long-term care insurance policy. Lancet 378, 1183–1192.
Varghese, C., and Shin, H.R. (2014). Strengthening cancer control in China. Lancet Oncol 15, 484–485.
Varlotto, J.M., Decamp, M.M., Flickinger, J.C., Lake, J., Recht, A., Belani, C.P., Reed, M.F., Toth, J.W., Mackley, H.B., Sciamanna, C.N., et al. (2014). Would screening for lung cancer benefit 75- to 84-year-old residents of the United States? Front Oncol 4, 37.
Wang, F.S., Fan, J.G., Zhang, Z., Gao, B., and Wang, H.Y. (2014). The global burden of liver disease: the major impact of China. Hepatology 60, 2099–2108.
Wang, S.X., Wu, J.L., Zheng, R.M., Xiong, W.Y., Chen, J.Y., Ma, L., and Luo, X.M. (2019). A preliminary cervical cancer screening cascade for eight provinces rural Chinese women. Chin Med J 132, 1773–1779.
Whitson, H.E., Heflin, M.T., and Burchett, B.M. (2006). Patterns and predictors of smoking cessation in an elderly cohort. J Am Geriatr Soc 54, 466–471.
Winters, S., Martin, C., Murphy, D., and Shokar, N.K. (2017). Breast cancer epidemiology, prevention, and screening. Prog Mol Biol Transl Sci 151, 1–32.
Wu, L., Huang, Z., and Pan, Z. (2021a). The spatiality and driving forces of population ageing in China. PLoS ONE 16, e0243559.
Wu, Y., Li, Y., and Giovannucci, E. (2021b). Potential impact of time trend of lifestyle risk factors on burden of major gastrointestinal cancers in China. Gastroenterology 161, 1830–1841.e8.
Zhang, B.H., Yang, B.H., and Tang, Z.Y. (2004). Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130, 417–422.
Zhang, M., Wu, R., Xu, H., Uhanova, J., Gish, R., Wen, X., Jin, Q., Gerald, M.Y., Nguyen, M.H., Gao, Y., et al. (2019). Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study. BMJ Open 9, e028248.
Zhang, S., Sun, K., Zheng, R., Zeng, H., Wang, S., Chen, R., Wei, W., and He, J. (2021). Cancer incidence and mortality in China, 2015. J Natl Cancer Center 1, 2–11.
Zheng, R., Zhang, S., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., and He, J. (2022). Cancer incidence and mortality in China, 2016. J Natl Cancer Center 2, 1–9.
Acknowledgements
This work was supported by the CAMS Innovation Fund for Medical Sciences (2021-I2M-1-011, 2021-12M-1-046). The authors express their deep gratitude to all the local Cancer Registry staff in China for their contribution to data collection, validation, and routine analyses.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Compliance and ethics
The author(s) declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Ju, W., Zheng, R., Zhang, S. et al. Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea. Sci. China Life Sci. 66, 1079–1091 (2023). https://doi.org/10.1007/s11427-022-2218-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-022-2218-x